HROW Q2 2025 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q2 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$64M+30.2% YoY

Gross Profit

$48M74.5% margin

Operating Income

$11M17.9% margin

Net Income

$5M7.8% margin

EPS (Diluted)

$0.13

QoQ Revenue Growth

+33.3%

Cash Flow

Operating Cash Flow

-$803,000

Free Cash Flow

-$969,000

Stock-Based Comp.

$875,000

Balance Sheet

Total Assets

$345M

Total Liabilities

$296M

Stockholders' Equity

$50M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64M	$49M	+30.2%
Gross Profit	$48M	$36M	+30.5%
Operating Income	$11M	$2M	+645.7%
Net Income	$5M	-$6M	+177.2%

Revenue Segments

Other Products

$5M98%

Other Revenue

$85,0002%